ACER THERAPEUTICS INC. Basic Shares Outstanding (Weighted Average)
ACER THERAPEUTICS INC. reported Basic Shares Outstanding (Weighted Average) of 24.46 million shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2023-11-20
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2023-09-30 was 24.46M shares, a 52.05% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 24.46M shares, a 60.16% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2023-03-31 was 21.11M shares, a 47.54% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was 17.38M shares, a 21.42% increase year-over-year.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 15.77M shares, a 10.51% increase from fiscal 2021.
- ACER THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2021 was 14.27M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2023-09-30 | 24.46M shares 10-Q · filed 2023-11-20 | 24.46M shares derived: average of 2 quarters · filed 2023-11-20 | 23.25M shares 10-Q · filed 2023-11-20 | 21.85M shares derived: average of 4 quarters · filed 2023-11-20 |
| 2023-06-30 | 24.46M shares 10-Q · filed 2023-08-14 | 22.77M shares 10-Q · filed 2023-08-14 | 20.98M shares derived: average of 3 quarters · filed 2023-08-14 | 19.76M shares derived: average of 4 quarters · filed 2023-11-20 |
| 2023-03-31 | 21.11M shares 10-Q · filed 2023-05-15 | 19.24M shares derived: average of 2 quarters · filed 2023-05-15 | 18.19M shares derived: average of 3 quarters · filed 2023-11-20 | 17.46M shares derived: average of 4 quarters · filed 2023-11-20 |
| 2022-12-31 | 17.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 16.73M shares derived: average of 2 quarters · filed 2023-11-20 | 16.25M shares derived: average of 3 quarters · filed 2023-11-20 | 15.77M shares 10-K · filed 2023-03-27 |
| 2022-09-30 | 16.09M shares 10-Q · filed 2023-11-20 | 15.68M shares derived: average of 2 quarters · filed 2023-11-20 | 15.23M shares 10-Q · filed 2023-11-20 | 15.00M shares derived: average of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | 15.27M shares 10-Q · filed 2023-08-14 | 14.79M shares 10-Q · filed 2023-08-14 | 14.63M shares derived: average of 3 quarters · filed 2023-08-14 | 14.55M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 14.31M shares 10-Q · filed 2023-05-15 | 14.31M shares derived: average of 2 quarters · filed 2023-05-15 | 14.31M shares derived: average of 3 quarters · filed 2023-05-15 | 14.31M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 14.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 14.31M shares derived: average of 2 quarters · filed 2023-03-27 | 14.31M shares derived: average of 3 quarters · filed 2023-03-27 | 14.27M shares 10-K · filed 2023-03-27 |
| 2021-09-30 | 14.31M shares 10-Q · filed 2022-11-14 | 14.31M shares derived: average of 2 quarters · filed 2022-11-14 | 14.25M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 14.31M shares 10-Q/A · filed 2022-11-14 | 14.23M shares 10-Q/A · filed 2022-11-14 |